Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate for Cervical Preparation in Second Trimester Abortion
NCT03802149Phase 1Completed
- Sponsor
- Stanford University
- Start
- Apr 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ulipristal in termination of pregnancy, sponsored by Stanford University. Primary endpoint: Adequacy of cervical dilation. Started Apr 2019; status: completed.
02
Drugs
ulipristal
03
Conditions
termination of pregnancy
Beyond the preview
Go deeper on NCT03802149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802149.